Literature DB >> 20086161

Pharmacokinetics of liposomal amphotericin B in pleural fluid.

Brad Moriyama1, Parizad Torabi-Parizi, Alexandra K Pratt, Stacey A Henning, Gennethel Pennick, Yvonne R Shea, Sinchita Roy Chowdhuri, Michael G Rinaldi, A John Barrett, Thomas J Walsh.   

Abstract

We report the penetration of liposomal amphotericin B into the pleural fluid of a patient with pulmonary zygomycosis and empyema. The ratio of area under the concentration-versus-time curve in pleural fluid (AUC(pleural fluid)) to that in serum (AUC(serum)) for liposomal amphotericin B over 24 h was 9.4%, with pleural fluid concentrations of 2.12 to 4.91 microg/ml. Given the relatively low level of intrapleural penetration of liposomal amphotericin B, chest tube drainage may be warranted for successful treatment of zygomycotic empyema.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20086161      PMCID: PMC2849376          DOI: 10.1128/AAC.01438-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Empyema thoracis due to Rhizopus oryzae in an allogenic bone marrow transplant recipient.

Authors:  Chih-Cheng Lai; Shwu-Jen Liaw; Yao-Chuan Hsiao; Yu-Shin Chiu; Wei-Yu Laio; Li-Na Lee; Po-Ren Hsueh
Journal:  Med Mycol       Date:  2006-02       Impact factor: 4.076

Review 2.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

Review 3.  Fatal course of pulmonary Absidia sp. infection in a 4-year-old girl undergoing treatment for acute lymphoblastic leukemia.

Authors:  Agnieszka Krauze; Katarzyna Krenke; Michal Matysiak; Marek Kulus
Journal:  J Pediatr Hematol Oncol       Date:  2005-07       Impact factor: 1.289

4.  A pharmacologic guide to the clinical use of amphotericin B.

Authors:  D D Bindschadler; J E Bennett
Journal:  J Infect Dis       Date:  1969-10       Impact factor: 5.226

Review 5.  Anatomy and physiology of the pleural space.

Authors:  N S Wang
Journal:  Clin Chest Med       Date:  1985-03       Impact factor: 2.878

6.  Cokeromyces recurvatus isolated from pleural and peritoneal fluid: case report.

Authors:  B Munipalli; M G Rinaldi; S B Greenberg
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

7.  Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer.

Authors:  Georgios Chamilos; Edith M Marom; Russell E Lewis; Michail S Lionakis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2005-05-24       Impact factor: 9.079

Review 8.  Cryptococcus albidus and mucormycosis empyema in a patient receiving hemodialysis.

Authors:  I D Horowitz; E A Blumberg; L Krevolin
Journal:  South Med J       Date:  1993-09       Impact factor: 0.954

9.  Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patients.

Authors:  G G Chabot; R Pazdur; F A Valeriote; L H Baker
Journal:  J Pharm Sci       Date:  1989-04       Impact factor: 3.534

10.  High-performance liquid chromatographic analysis of amphotericin B in plasma, blood, urine and tissues for pharmacokinetic and tissue distribution studies.

Authors:  L H Wang; P C Smith; K L Anderson; R M Fielding
Journal:  J Chromatogr       Date:  1992-09-02
View more
  9 in total

1.  Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema.

Authors:  Brad Moriyama; Marisa Ditullio; Eleanor Wilson; Stacey A Henning; Scott R Penzak; Robert L Danner; Gennethel Pennick; Michael G Rinaldi; Adrian M Zelazny; Juan Gea-Banacloche; A John Barrett; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

2.  Melanoma brain metastases: is it time to reassess the bias?

Authors:  Jaclyn C Flanigan; Lucia B Jilaveanu; Mark Faries; Mario Sznol; Stephan Ariyan; James B Yu; Jonathan P S Knisely; Veronica L Chiang; Harriet M Kluger
Journal:  Curr Probl Cancer       Date:  2011 Jul-Aug       Impact factor: 3.187

Review 3.  Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions.

Authors:  Neil R H Stone; Tihana Bicanic; Rahuman Salim; William Hope
Journal:  Drugs       Date:  2016-03       Impact factor: 9.546

4.  Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome.

Authors:  Jun Feng; Xuefeng Sun
Journal:  Infection       Date:  2018-05-10       Impact factor: 3.553

Review 5.  Tissue penetration of antifungal agents.

Authors:  Timothy Felton; Peter F Troke; William W Hope
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

6.  A 19-year-old woman with pleuritic chest pain.

Authors:  Faisal A Khasawneh; Mansoor Mehmood; Ruba A Halloush
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Mar-Apr       Impact factor: 2.471

7.  Refractory bronchovascular pleuropulmonary mucormycosis: Case report and difficulties in management.

Authors:  M Manjunath; Deepak Prajapat; Rahul Kumar Sharma; Deepak Talwar
Journal:  Lung India       Date:  2018 Jan-Feb

Review 8.  Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents.

Authors:  Valentin Al Jalali; Markus Zeitlinger
Journal:  Clin Pharmacokinet       Date:  2020-07       Impact factor: 6.447

9.  A Case Report of Histoplasma-Associated Empyema Treated With Intravenous Injection and Local Thoracic Irrigation of Amphotericin B Plus Medical Thoracoscopy.

Authors:  Ning Cui; Lijun Wang; Jingming Zhao
Journal:  Front Public Health       Date:  2022-07-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.